David Yi is a member of the intellectual property group. Before joining us, he completed a clerkship at the Federal Court with the Honourable Mr. Justice Zinn. Prior to that, he was a summer and articling student at a national law firm in Toronto.
Mr. Yi has participated and coached in a variety of advocacy competitions, including the Harold G. Fox Intellectual Property Moot. In law school, he worked as both a research and teaching assistant and was the director of the Pro Bono Students Canada Wills Clinic.
The Ontario Superior Court of Justice dismissed the defendants’ motion for summary judgment in Apotex’s action for s. 8 damages..
March 20, 2017
The Federal Court of Appeal upheld findings of the Federal Court declaring the asserted claims of Canadian Patent No. 1,292,693 to be valid and infringed by Apotex’s manufacture, sale, and promotion of Apo-Omeprazole capsules, a generic version of AstraZeneca’s LOSEC®, but allowed Apotex’s appeal in respect of the appropriate limitation period for infringing activities..
January 18, 2017